491
|
|
|
Dynein regulatory complex subunit 2 |
CCDC65, CFAP250, FAP250, NYD-SP28 |
|
492
|
|
|
Dynein regulatory complex subunit 3 |
CFAP134, LRRC48 |
|
493
|
|
|
Dynein regulatory complex subunit 4 |
CILD33, GAS11, GAS8 |
|
494
|
|
|
Dopamine receptor D1 |
D1R, DADR, DRD1A |
Amphetamine or sympathomimetic abuse, Autism, Bipolar disorder, Catalepsy, Bipolar depression, Major depressive disorder, Dyskinesia, drug-induced, Hyperkinesia, Hypertension, Hypotension, Kidney failure, Movement disorder, Obesity, Parkinson disease, Depression, Rheumatoid arthritis, Schizophrenia, Seizures, Venous thromboembolismView all (4 more) |
495
|
|
|
Dopamine receptor D2 |
D2DR, D2R |
Amphetamine or sympathomimetic abuse, Anhedonia, Anorexia nervosa, Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Basal ganglia disease, Bipolar disorder, Bradycardia, Cannabis abuse, Catalepsy, Chiari-frommel syndrome, Lymphocytic leukemia, Obstructive pulmonary disease, Cognition disorder, Color vision deficiency, Delirium, Delirium, dementia, and cognitive disorders, Major depressive disorder, Developmental disability, Diabetes mellitus type 2, Disruptive, impulse control, and conduct disorders, Dyskinesia, drug-induced, Dyskinesia, Hyperkinesia, Hyperproinsulinemia, Hypertension, Hypotension, Kidney failure, Language development disorders, Memory disorders, Migraine, Mood disorder, Movement disorder, Myoclonic dystonia, Neurotic disorder, Obesity, Obsessive-compulsive disorder, Osteoarthritis, Parkinson disease, Pituitary neoplasms, Psychiatric disorders, Depression, Schizophrenia, Seizures, Substance abuse, Tourette syndromeView all (32 more) |
496
|
|
|
Dopamine receptor D3 |
D3DR, ETM1, FET1 |
Amphetamine or sympathomimetic abuse, Asthma, Autism, Basal ganglia disease, Bipolar disorder, Cognition disorder, Congenital heart disease, Delirium, Delirium, dementia, and cognitive disorders, Major depressive disorder, Disruptive, impulse control, and conduct disorders, Dyskinesia, drug-induced, Essential tremor, Tremor, Tourette syndrome, Hyperalgesia, Hyperkinesia, Mood disorder, Movement disorder, Depression, Schizophrenia, Seizures, Smooth surface dental cariesView all (8 more) |
497
|
|
|
Dopamine receptor D4 |
D4DR |
Amphetamine or sympathomimetic abuse, Antisocial personality disorder, Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Cannabis abuse, Conduct disorder, Major depressive disorder, Dyslexia, Tourette syndrome, Hodgkin lymphoma, Internet addiction disorder, Liver cirrhosis, Intellectual developmental disorder, Mood disorder, Myositis, Rheumatoid arthritis, Schizophrenia, Scoliosis, Seasonal affective disorder, Separation anxiety disorder, Systemic lupus erythematosus, Systemic sclerosis, DepressionView all (10 more) |
498
|
|
|
Dopamine receptor D5 |
DBDR, DRD1B, DRD1L2 |
|
499
|
|
|
Developmentally regulated GTP binding protein 1 |
NEDD3, TANALS |
|
500
|
|
|
Developmentally regulated GTP binding protein 2 |
- |
|
